BPC-157 and Hexarelin Interaction

Synergistic
Mechanism-based 47% confidence

BPC-157 and Hexarelin have a synergistic interaction with 47% confidence. BPC-157 and Hexarelin work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. These compounds primarily affect different organ systems.

Compound Profiles

BPC-157

Body Protection Compound-157 | Pentadecapeptide

Promotes blood vessel formation (angiogenesis), enhances collagen synthesis, modulates growth factor expression including VEGF, and protects against tissue damage through localized or systemic delivery pathways..

Half-life: <30 minutes Typical dose: 250-500mcg healing, longevity
vegf anticoagulantcarcinogenic riskpro angiogenicteratogenic
View full profile

Hexarelin

Examorelin | Synthetic Growth Hormone Secretagogue

Hexarelin binds to the growth hormone secretagogue receptor 1a (GHS-R1a) in the brain and pituitary gland. This binding initiates a signaling cascade that stimulates somatotroph cells in the anterior pituitary to produce and release growth hormone.

Half-life: 1-2 hours Typical dose: 100-200 mcg per injection growth hormone, weight loss
ghrelin receptorprolactin receptor carcinogenic riskinsulin disruptingprolactin elevatingteratogenic
View full profile

Combined Organ Load

Blood Vessels
low
GI Tract
low
Pituitary
low

Shared Safety Flags

2x 2 compounds share the carcinogenic-risk safety flag (BPC-157, Hexarelin). Monitor accordingly.
2x 2 compounds share the teratogenic safety flag (BPC-157, Hexarelin). Monitor accordingly.

Frequently Asked Questions

Can I take BPC-157 with Hexarelin?

Yes, BPC-157 and Hexarelin can generally be taken together. BPC-157 and Hexarelin work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols.

Is BPC-157 and Hexarelin safe together?

Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: carcinogenic risk, teratogenic. Monitor accordingly.

What are the interactions between BPC-157 and Hexarelin?

BPC-157 and Hexarelin work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.

How should I time BPC-157 and Hexarelin?

BPC-157 has a half-life of <30 minutes and Hexarelin has a half-life of 1-2 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: BPC-157 vs Hexarelin

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.